https://www.indianpharmapost.com/acg-to-invest-200-million-in-us-hard-shell-capsule-manufacturing-180372025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvies-rinvoq-beats-humira-in-key-arthritis-trial-180522025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-presents-positive-phase-iii-data-for-vamikibart-in-uveitic-macular-edema-180512025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/lundbeck-and-contera-pharma-join-forces-to-advance-rna-therapies-for-neurological-disorders-180502025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/keytruda-lenvima-shows-durable-5-year-survival-benefit-in-advanced-endometrial-cancer-180492025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/johnson-johnsons-rybrevant-shows-45-response-rate-in-hnscc-180482025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/rpg-life-sciences-posts-q2-fy26-pat-at-rs-3685-cr-180472025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/qureai-receives-regulatory-clearance-for-ai-tool-for-early-detection-of-tb-in-children-below-3-years-180462025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/ttk-healthcare-reports-q2-fy26-net-profit-at-rs-2038-cr-180452025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/bajaj-healthcare-posts-q2-fy26-pat-at-rs-1110-cr-180442025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/merck-breaks-ground-on-3-billion-center-of-excellence-for-pharma-manufacturing-in-virginia-180432025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/pfizers-braftovimektovi-shows-sustained-long-term-survival-in-patients-with-advanced-lung-cancer-180422025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/enzalutamide-leads-to-40-lower-risk-of-death-in-prostate-cancer-180412025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/abbvie-completes-acquisition-of-gilgamesh-pharmaceuticals-bretisilocin-180402025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/astrazenecas-imfinzi-cuts-death-risk-by-32-in-high-risk-non-muscle-invasive-bladder-cancer-180392025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-roches-kidney-inflammation-drug-180382025-10-22T00:00:00+05:30always0.9https://www.indianpharmapost.com/cambrex-to-invest-120-million-to-expand-api-manufacturing-in-us-180532025-10-22T00:00:00+05:30always0.9